Ethic Inc. Boosts Stock Position in Amgen Inc. $AMGN

Ethic Inc. significantly increased its stake in Amgen Inc. by 10.4% in the fourth quarter, bringing its total holdings to $15.08 million. Other institutional investors also adjusted their positions in Amgen, which recently announced a quarterly dividend and favorable Q1 earnings, beating analyst estimates. Wall Street analysts currently hold a “Hold” rating on Amgen with a consensus target price of $357.12.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin